Drugs / LCAR1901
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06973356 | Aug 2025 → Jun 2029 expected | autoimmune thrombocytopenia | Anhui Provincial Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LCAR1901 | “An Exploratory Clinical Study of Anti-CD19/BCMA CAR gene vector injection (LCAR1901) for the Treatment of Relapsed and Refractory Immune Thrombocytopenia” NCT06973356 ↗ |
| Route | Intravenous | “A single intravenous infusion of anti-CD19/BCMA CAR gene vector injection” NCT06973356 ↗ |
| Target | CD19 | “Anti-CD19/BCMA CAR gene vector injection” NCT06973356 ↗ |